(Q44207271)

30 November 2017

title

Treatment of pancreatic cancer xenografts with Erbitux (IMC-C225) anti-EGFR antibody, gemcitabine, and radiation (English)

1 reference

30 November 2017

1 reference

1 reference

1 reference

3

William E Grizzle

1 reference

30 November 2017

6

Daniel J Hicklin

1 reference

30 November 2017

Donald J Buchsbaum

1

1 reference

30 November 2017

James A Bonner

2

1 reference

30 November 2017

Murray A Stackhouse

4

1 reference

30 November 2017

Mark Carpenter

5

1 reference

30 November 2017

Peter Bohlen

7

1 reference

30 November 2017

Kevin P Raisch

8

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

International Journal of Radiation Oncology Biology Physics

30 November 2017

published in

1 reference

30 November 2017

volume

54

1 reference

30 November 2017

issue

4

1 reference

30 November 2017

page(s)

1180-1193

1 reference

The EGF receptor system as a target for antitumor therapy

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903788-4

7 January 2021

Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903788-4

7 January 2021

Expression of metastasis-related genes in surgical specimens of human gastric cancer can predict disease recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903788-4

7 January 2021

Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903788-4

7 January 2021

Growth factor receptors are differentially expressed in cancers of the papilla of vater and pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903788-4

7 January 2021

Epidermal growth factor receptor blockade by antibody IMC-C225 inhibits growth of a human pancreatic carcinoma xenograft in nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903788-4

7 January 2021

The biologic effects of C225, a chimeric monoclonal antibody to the EGFR, on human prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903788-4

7 January 2021

Apoptosis induced by an anti-epidermal growth factor receptor monoclonal antibody in a human colorectal carcinoma cell line and its delay by insulin

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903788-4

7 January 2021

Combined modality therapy of A431 human epidermoid cancer using anti-EGFr antibody C225 and radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903788-4

7 January 2021

Epidermal growth factor receptor family and chemosensitization

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903788-4

7 January 2021

Phase I studies of anti-epidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903788-4

7 January 2021

Therapeutic application of anti-growth factor receptor antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903788-4

7 January 2021

Phase I study of anti--epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903788-4

7 January 2021

Radiosensitization of pancreatic cancer cells by 2',2'-difluoro-2'-deoxycytidine

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903788-4

7 January 2021

Phase I study of twice-weekly gemcitabine and concomitant external-beam radiotherapy in patients with adenocarcinoma of the pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903788-4

7 January 2021

Computer programs for the analysis of cellular survival data.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903788-4

7 January 2021

The interaction of epidermal growth factor and radiation in human head and neck squamous cell carcinoma cell lines with vastly different radiosensitivities

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903788-4

7 January 2021

Maximizing therapeutic gain with gemcitabine and fractionated radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903788-4

7 January 2021

Androgenic regulation of growth factor and growth factor receptor expression in the CWR22 model of prostatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903788-4

7 January 2021

Cancer statistics, 2000.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903788-4

7 January 2021

Chemotherapy for pancreatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903788-4

7 January 2021

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903788-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903788-4

1 reference

7 January 2021

Head and neck cancer as a clinical model for molecular targeting of therapy: combining EGFR blockade with radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903788-4

7 January 2021

Fibroblast growth factor and insulin-like growth factor differentially modulate the apoptosis and G1 arrest induced by anti-epidermal growth factor receptor monoclonal antibody.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903788-4

7 January 2021

Radiosensitizing potential of gemcitabine (2',2'-difluoro-2'-deoxycytidine) within the cell cycle in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903788-4

7 January 2021

10.1016/S0360-3016(02)03788-4

Identifiers

DOI

1 reference

30 November 2017

1 reference